<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02131571</url>
  </required_header>
  <id_info>
    <org_study_id>FractaVIH 117/13</org_study_id>
    <secondary_id>EC 117/13</secondary_id>
    <nct_id>NCT02131571</nct_id>
  </id_info>
  <brief_title>Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years</brief_title>
  <acronym>FractaVIH</acronym>
  <official_title>Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years: Importance of Bone Mineral Density and Bone Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective cohort study to determine the prevalence of vertebral fractures in HIV infected
      patients older than 50 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the prevalence of asymptomatic vertebral fractures in HIV patients older than 50
      years, and the risk of fracture during a follow up of 2 years, according to bone mineral
      density at inclusion, the level of serum bone biomarkers, and the presence of secondary
      factors such as hypovitaminosis D or/and secondary hyperparathyroidism.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of vertebral fractures in HIV patients older than 50 years</measure>
    <time_frame>2 years</time_frame>
    <description>To determine by lumbar and thoracic x ray the presence of vertebral fractures and the changes in vertebral form or size, according to Genant methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk of vertebral alteration according to bone mineral density and serum biomarkers</measure>
    <time_frame>2 years</time_frame>
    <description>To determine the relationships of vertebral alterations with bone mineral density by dual X-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vertebral alterations during follow up</measure>
    <time_frame>2 years</time_frame>
    <description>To determine the emergence of vertebral alterations during 2 years of follow up according to bone mineral density, bone biomarkers (osteocalcin, beta-crosslaps), and vitamin D/parathyroid hormone (PTH) status.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Vertebral Fractures</condition>
  <arm_group>
    <arm_group_label>HIV patients older than 50 years</arm_group_label>
    <description>HIV infected patients older than 50 years in current follow up</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        HIV infected patients older than 50 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 50 years

          -  HIV infection

        Exclusion Criteria:

          -  Pregnancy

          -  Receiving corticosteroids or antiresorptive therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose L Casado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramon y Cajal Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose L Casado, MD</last_name>
    <phone>34913368672</phone>
    <email>jcasado.hrc@salud.madrid.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ramon y Cajal Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose L Casado, MD</last_name>
      <phone>34913368672</phone>
      <email>jcasado.hrc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose L Casado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Vazquez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Maciá, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara Bañón, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Rosillo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2014</study_first_submitted>
  <study_first_submitted_qc>May 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2014</study_first_posted>
  <last_update_submitted>March 15, 2017</last_update_submitted>
  <last_update_submitted_qc>March 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>bone</keyword>
  <keyword>fractures</keyword>
  <keyword>vitamin D</keyword>
  <keyword>biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Spinal Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

